Kabra Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	603	583	263	32	24	20
Market Cap Growth	494.59%	121.84%	732.49%	29.08%	22.42%	0.89%
Enterprise Value	502	470	248	48	36	29
Last Close Price	25.43	24.58	11.08	7.19	5.57	4.55
PE Ratio	12.17	11.75	-	-	-	-
PS Ratio	0.65	0.63	-	-	-	-
PB Ratio	2.04	1.97	1.07	2.91	-3.34	-5.08
P/TBV Ratio	2.04	1.97	1.07	2.91	-	-
EV/Sales Ratio	0.54	0.51	-	-	-	-
EV/EBITDA Ratio	9.43	8.89	-	-	-	-
EV/EBIT Ratio	9.55	8.95	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.02	1.58	-1.89	-2.61
Debt / EBITDA Ratio	0.11	0.11	-	-	-	-
Net Debt / Equity Ratio	-0.34	-0.34	-0.85	-0.93	-1.89	-2.61
Net Debt / EBITDA Ratio	-1.90	-1.90	12.17	-	-4.12	-5.88
Net Debt / FCF Ratio	0.99	0.99	4.39	4.83	-3.89	-7.66
Asset Turnover	1.66	1.66	-	-	-	-
Quick Ratio	1.44	1.44	38.24	0.95	0.42	0.54
Current Ratio	1.48	1.48	43.84	1.30	0.47	0.63
Return on Equity (ROE)	18.28%	18.28%	-8.44%	-418.41%	-	-
Return on Assets (ROA)	5.90%	5.90%	-7.24%	-17.44%	-30.03%	-10.80%
Return on Invested Capital (ROIC)	26.57%	39.12%	-90.19%	-203.14%	-53.82%	-28.03%
Return on Capital Employed (ROCE)	17.70%	17.70%	-7.00%	-68.00%	47.10%	46.90%
Earnings Yield	8.23%	8.51%	-4.13%	-23.33%	-13.82%	-9.29%
FCF Yield	-16.88%	-17.46%	-18.11%	-6.61%	-14.50%	-6.70%
Buyback Yield / Dilution	-117.16%	-117.16%	-149.01%	-	-	-